Doctor of Dentistry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Kenneth Whitworth

Dentist, Oral and Maxillofacial Pathology Temecula, CA Doctor of Dentistry

NPI 1124146022 CMS profile 1050078

41619 Margarita Rd Ste 102, Temecula, CA 92591

Open in the dashboard

General payments

$33,402

305 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Kenneth Whitworth of Temecula, CA is reported in the CMS Open Payments database as having received $33,402 across 305 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Dentist, Oral and Maxillofacial Pathology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $4,049 11
2024 General $794 19
2023 General $3,517 17
2022 General $9,865 73
2021 General $8,727 59
2020 General $1,474 46
2019 General $4,976 80

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kenneth Whitworth
  • Dentist, Oral and Maxillofacial Pathology median
  • Middle half of Dentist, Oral and Maxillofacial Pathology
  • National median

In program year 2025, general payments to Kenneth Whitworth were reported at $4,049. Among 128 Dentist, Oral and Maxillofacial Pathology profiles paid that year, the median was $91 and the middle half received between $35 and $330.

Show as a table
Year Kenneth Whitworth Dentist, Oral and Maxillofacial Pathology median Middle half National median
2019 $4,976 $106 $28–$326 $163
2020 $1,474 $109 $33–$500 $114
2021 $8,727 $104 $30–$557 $132
2022 $9,865 $104 $37–$432 $149
2023 $3,517 $152 $41–$372 $160
2024 $794 $100 $38–$354 $164
2025 $4,049 $91 $35–$330 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Straumann USA LLC $22,470 84 payments
  2. Zimmer Biomet Holdings, Inc. $5,407 148 payments
  3. Keystone Dental Inc. $2,767 5 payments
  4. Zimvie Inc. $2,526 58 payments
  5. Salvin Dental Specialties, Inc. $98 3 payments
  6. Implant Direct Sybron International LLC $42 1 payment
  7. Geistlich Pharma, North America, Inc. $35 2 payments
  8. KLS-Martin L.P. $29 2 payments
  9. BioHorizons Implant Systems Inc. $29 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $14,563 271 payments
  2. Gift $7,640 16 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $7,195 9 payments
  4. Travel and Lodging $2,846 4 payments
  5. Entertainment $1,009 3 payments
  6. Education $150 2 payments
Products named General payments · program years 2019–2025
  1. All T3 Implants Dental $2,571 65 payments
  2. Diem2 $1,271 38 payments
  3. All T3 Implants Dental $955 21 payments
  4. 3i T3 $623 11 payments
  5. Diem2-RevitaliZe $517 9 payments
  6. T3 $291 6 payments
  7. Puros $145 6 payments
  8. BioMend $106 1 payment
  9. Bellatek $98 3 payments
  10. Socket Repair Membrane $87 1 payment
  11. Other $683 43 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 13 drugs

Part D claims

1,145

Median for Dentist: 47

Drug cost

$5,907

Median for Dentist: $159

Branded share of claims

42.7%

Median for Dentist: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Chlorhexidine Gluconate Generic 275 $1,714
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 172 $1,266
Amoxicillin Generic 254 $1,011
Ondansetron Odt Ondansetron Brand 192 $500
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 77 $412
Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav Brand 26 $245
Clindamycin Hcl Generic 34 $234
Cefuroxime Cefuroxime Axetil Brand 22 $199
Ibuprofen Generic 28 $113
Oxycodone Hcl Generic 26 $87

The 10 drugs with the highest cost, of 13 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 110,731 Part D prescribers listed as Dentist; they describe a distribution and say nothing about conduct.

Records

305 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dentist, Oral and Maxillofacial Pathology in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record